Candidature YC de Relevium Medical

Summer 2022Active

Relevium Medical a été sélectionné par Y Combinator dans le cadre du batch Summer 2022 en tant qu'entreprise Healthcare. Ci-dessous : ce que fait l'entreprise, qui l'a fondée, et sa candidature à YC, reconstruite question par question dans le vrai formulaire YC.

Batch YC: Summer 2022
Secteur d'activité: HealthcareTherapeutics
Taille de l'équipe: 5
Statut: Active
Lancé: 2022

Fondateurs

Alison LiddyFounder

Ce que fait Relevium Medical

Relevium Medical is developing an injectable gel for knee osteoarthritis. Approximately half the population will be diagnosed with this pain and progressive disease. Right now, patients have to undergo not only repeat injections to control their pain, but also have to take strong oral medications. Because the disease is progressive and only gets worse over time, many patients end up on highly addictive, high-dose opioids. To date, we have secured $3.7 million in non dilutive funding and completed preclinical testing. We demonstrated that our drug is safe, selectively blocks nerves that transmit pain, and provides pain relief that lasts four times as long. Insurance currently pays $770 per six-monthly treatment for knee osteoarthritis. With 5 million patients in the US, this represents a $7.7 Bn market opportunity. This platform biotherapeutic can also be used to treat other joints affects by osteoarthritis such as the hip and ankle, where the same problems exist in treatment care.

Candidature YC de Relevium Medical, reconstruite

Candidature Y Combinator

Relevium Medical, promotion Summer 2022. Les vraies questions de candidature, répondues à partir de données publiques.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Relevium Medical

Describe what your company does in 50 characters or less.

Injectable gel therapy for osteoarthritis

What is your company going to make? Please describe your product and what it does or will do.

We are developing a platform injectable gel designed to provide long-lasting pain relief for knee osteoarthritis patients. Our gel selectively blocks the pain-transmitting nerves and significantly extends the duration of relief compared to current treatments. It aims to reduce reliance on repeated injections and opioids.

Where do you live now, and where would the company be based after YC?

We live and work in Galway, County Galway, Ireland, and plan to keep the company based there after YC.

Explain your decision regarding location.

We are based in Galway where we have access to local talent and medical expertise relevant to our therapeutic development. Remaining here supports our preclinical testing and product development continuity.

21 réponses supplémentaires dans la candidature complète

se trouvent dans la version complète. Créez un compte gratuit pour l'ouvrir dans YC Insights, à côté de tous les autres batches YC.

Voir la candidature complète

Questions fréquemment posées

Est-ce la vraie candidature YC de Relevium Medical ?

Non. Y Combinator garde les candidatures soumises privées. Ceci est une reconstruction : les vraies questions du formulaire YC, répondues à partir des données publiques de Relevium Medical (notes de lancement, parcours des fondateurs, description du produit). Cela montre comment une entreprise comme Relevium Medical se présenterait à YC, pas le texte qu'ils ont soumis.

À quel batch YC Relevium Medical appartenait-il ?

Relevium Medical faisait partie du batch Summer 2022 de Y Combinator.

Qui a fondé Relevium Medical ?

Relevium Medical a été fondé par Alison Liddy.

Que fait Relevium Medical ?

Platform injectable gel based therapeutic for osteoarthritis

Comment lire la candidature complète reconstruite ?

Créez un compte Round Funded gratuit. La version complète de la candidature de Relevium Medical en 26 réponses, et de chaque autre promotion YC, se trouve dans YC Insights.